Literature DB >> 10874070

Warfarin for cancer prevention.

C C Zielinski, M Hejna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10874070     DOI： 10.1056/NEJM200006293422612

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Authors:  L Borsig; R Wong; J Feramisco; D R Nadeau; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable.

Authors:  Thomas P Ahern; Lars Pedersen; Claus Sværke; Kenneth J Rothman; Henrik Toft Sørensen; Timothy L Lash
Journal:  Am J Epidemiol       Date:  2011-11-01       Impact factor: 4.897

Review 3.  Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.

Authors:  Luise Erpenbeck; Michael P Schön
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

Review 4.  Molecular mechanisms of metastasis in breast cancer--clinical applications.

Authors:  Michal Mego; Sendurai A Mani; Massimo Cristofanilli
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

5.  Determining the anti-coagulant-independent anti-cancer effects of heparin.

Authors:  V Solari; E C Jesudason; J E Turnbull; E A Yates
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

Review 6.  Circulating tumor cells in breast cancer: a tool whose time has come of age.

Authors:  Ramona F Swaby; Massimo Cristofanilli
Journal:  BMC Med       Date:  2011-04-21       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.